NorthStar Medical Announces Mo-99 Production Milestone

NorthStar Medical Radioisotopes announced yesterday the successful first production-scale test run of molybdenum-99 from its system at the University of Missouri Research Reactor (MURR) in Columbia, Mo. Following the test run at the reactor, NorthStar then shipped the material to its Madison, Wis. facility, another milestone for the company’s production process. “This week’s events proved that NorthStar, working in concert with MURR, can seamlessly produce, package and ship customers’ orders of Mo-99,” said James Harvey, NorthStar senior vice president and chief science officer. According to the company, the Mo-99 aliquoting system filled several depleted uranium source vessels and one tungsten source vessel with Mo-99 on May 4. On May 5, the package, made up of 400 curies of Mo-99, arrived in good condition for inspection and recycling in Madison.